Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-268076
Filing Date
2025-11-06
Accepted
2025-11-06 07:16:01
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20250930.htm   iXBRL 10-Q 2599370
2 EX-31.1 ivvd-ex31_1.htm EX-31.1 19385
3 EX-32.1 ivvd-ex32_1.htm EX-32.1 11745
  Complete submission text file 0001193125-25-268076.txt   9924289

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250930.xsd EX-101.SCH 1347917
76 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250930_htm.xml XML 1794522
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 251456136
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)